Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Phillip S. Leventhal"'
Autor:
Sandrine I. Samson, Phillip S. Leventhal, Camille Salamand, Ya Meng, Bruce T. Seet, Victoria Landolfi, David Greenberg, Rosalind Hollingsworth
Publikováno v:
Expert Review of Vaccines, Vol 18, Iss 3, Pp 295-308 (2019)
Introduction: High-dose trivalent, inactivated, split-virus influenza vaccine (IIV3-HD) has been available in the US since 2009 for adults aged ≥ 65 years. To better understand how IIV3-HD provides improved protection against influenza, we systemat
Externí odkaz:
https://doaj.org/article/78a740013bef45de9ac94c5284ba147e
Autor:
Viviane Gresset-Bourgeois, Phillip S. Leventhal, Stéphanie Pepin, Rosalind Hollingsworth, Marie-Pierre Kazek-Duret, Iris De Bruijn, Sandrine I. Samson
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 1, Pp 1-11 (2018)
Introduction: VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age. IIV4 builds on the well-established record of the trivalent split-virion influenza v
Externí odkaz:
https://doaj.org/article/96a34f53a52544b3a440976e65d92e89
Autor:
Patrice Dubreuil, Olivier Hermine, Jean-Pierre Kinet, Alain Moussy, Stéphanie Guéry, Phillip S. Leventhal, Fabienne Palmérini, Katia Hanssens, Ying Yang, Sébastien Letard
Supplementary Figure S1 from Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::599a2f64b9d8e93ed8bee6cd35079049
https://doi.org/10.1158/1541-7786.22518484
https://doi.org/10.1158/1541-7786.22518484
Autor:
Patrice Dubreuil, Olivier Hermine, Jean-Pierre Kinet, Alain Moussy, Stéphanie Guéry, Phillip S. Leventhal, Fabienne Palmérini, Katia Hanssens, Ying Yang, Sébastien Letard
In the current study, we examined the types and frequency of KIT mutations in mast cell tumors from 191 dogs. Sequencing of reverse transcription-PCR products revealed alterations in 50 (26.2%) of the dogs. Most mutations were in exon 11 (n = 32), an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abe49c38bd7b95b03f355c656aa918fb
https://doi.org/10.1158/1541-7786.c.6541942.v1
https://doi.org/10.1158/1541-7786.c.6541942.v1
Autor:
Ya Meng, Sandrine I. Samson, Phillip S Leventhal, Rosalind Hollingsworth, Bruce T. Seet, Victoria Landolfi, Camille Salamand, David A. Greenberg
Publikováno v:
Expert Review of Vaccines. 18:295-308
Introduction: High-dose trivalent, inactivated, split-virus influenza vaccine (IIV3-HD) has been available in the US since 2009 for adults aged ≥ 65 years. To better understand how IIV3-HD provides improved protection against influenza, we systemat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2af5a4fd73b7c973aeaf2a08a31ea4c
https://doi.org/10.1080/14760584.2019.1575734
https://doi.org/10.1080/14760584.2019.1575734
Autor:
Patrice Dubreuil, Sébastien Letard, Marco Ciufolini, Laurent Gros, Martine Humbert, Nathalie Castéran, Laurence Borge, Bérengère Hajem, Anne Lermet, Wolfgang Sippl, Edwige Voisset, Michel Arock, Christian Auclair, Phillip S Leventhal, Colin D Mansfield, Alain Moussy, Olivier Hermine
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e7258 (2009)
BackgroundThe stem cell factor receptor, KIT, is a target for the treatment of cancer, mastocytosis, and inflammatory diseases. Here, we characterise the in vitro and in vivo profiles of masitinib (AB1010), a novel phenylaminothiazole-type tyrosine k
Externí odkaz:
https://doaj.org/article/63537d296c7e47bf89a26c076d6d1533
Autor:
Olivier Hermine, Olivier Lortholary, Phillip S Leventhal, Adeline Catteau, Frédérique Soppelsa, Cedric Baude, Annick Cohen-Akenine, Fabienne Palmérini, Katia Hanssens, Ying Yang, Hagay Sobol, Sylvie Fraytag, David Ghez, Felipe Suarez, Stéphane Barete, Philippe Casassus, Beatrice Sans, Michel Arock, Jean Pierre Kinet, Patrice Dubreuil, Alain Moussy
Publikováno v:
PLoS ONE, Vol 3, Iss 5, p e2266 (2008)
BackgroundIndolent forms of mastocytosis account for more than 90% of all cases, but the types and type and severity of symptoms and their impact on the quality of life have not been well studied. We therefore performed a case-control cohort study to
Externí odkaz:
https://doaj.org/article/c7a9aa9cd18f44c892d09c46322acbf3
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology
Skin aging is primarily due to alterations in the dermal extracellular matrix, especially a decrease in collagen I content, fragmentation of collagen fibrils, and accumulation of amorphous elastin material, also known as elastosis. Growth factors and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53174e991d1f0ed070f4e108f9de7a31
https://doi.org/10.2147/ccid.s116158
https://doi.org/10.2147/ccid.s116158
Autor:
Phillip S Leventhal, Marie-Pierre Kazek-Duret, Stephanie Pepin, Rosalind Hollingsworth, Sandrine I. Samson, Viviane Gresset-Bourgeois, Iris De Bruijn
Publikováno v:
Expert review of vaccines. 17(1)
Introduction: VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age. IIV4 builds on the well-established record of the trivalent split-virion influenza v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39705b47820b5ac51fad22868f6e547
https://pubmed.ncbi.nlm.nih.gov/29157068
https://pubmed.ncbi.nlm.nih.gov/29157068
IncobotulinumtoxinA for Aesthetic Indications: A Systematic Review of Prospective Comparative Trials
Publikováno v:
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 43(7)
IncobotulinumtoxinA is a botulinum toxin type A (BoNTA) indicated for temporary improvement in the appearance of upper facial lines with well-established efficacy and safety profiles. Whether incobotulinumtoxinA and other BoNTAs are equipotent is sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ffd61d90d63d38dc65aca8baaf26a7
https://pubmed.ncbi.nlm.nih.gov/28375973
https://pubmed.ncbi.nlm.nih.gov/28375973